Use of metformin and sodium butyrate for treating conditions induced by chronic inflammation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11382878
APP PUB NO 20210015769A1
SERIAL NO

16618161

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are compositions and methods for the treatment of conditions induced by chronic inflammation. According to some embodiments, the compositions and methods involve the use of metformin and sodium butyrate in the treatment of conditions induced by chronic inflammation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JOHNPRO BIOTECH INC2F -98 NO 163 NANJING W RD DATONG DIST TAIPEI CITY 103

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheng, Kai-Chung Taipei, TW 10 10
Chi, Kwan-Hwa Taipei, TW 12 16
Chiang, Hsin-Chien Taipei, TW 13 14
Wang, Yu-Shan Taipei, TW 13 41

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 12, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 12, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 12, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00